An interventional study of Graston technique and Myofascial Release Therapy in Cervicogenic Headache, sponsored by Riphah International University. Not yet recruiting. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
Cervicogenic Headache (CGH) is a painful condition that has pronounced impacts on quality and activity of daily lives. It is often associated with decreased mobility, muscular tightness, and postural deviations. When neck muscles become tight, weak, or irritated, they change the way the neck moves and put pressure on nearby joints and nerves. This pressure delivers pain signals to the head, causing a Cervicogenic headache.
The aim of this study is to compare the effects of the Graston Technique and Myofascial Release in reducing pain, improving cervical range of motion, and decreasing functional disability in patients with Cervicogenic headache.
This study will be a randomized control trial and will be take place at Sehat Medical Complex, lake city branch, Lahore. Non-probability convenience sampling will be used to collect data. Sample size of ( ) subjects with age group between 18-40 years will be taken. Data will be collected from the patients having present complaint of Cervicogenic headache. Outcome measures will be assessed using numeric pain rating scale (NPRS) for pain, Neck Disability Index (NDI) to measure neck related disability, Headache Disability Index (HDI) to assess the impact of headaches on daily activities and emotional well-being and Goniometer for assessing range of motions. An informed consent will be taken and subjects will be selected on basis of inclusion and exclusion criteria. They will be divided into two groups by random number generator. One group will receive Graston technique and other myofascial release as a treatment while both groups will be receiving conventional treatment alongside. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 21.
192 studies on the registry are indexed under Post-Traumatic Headache; 54 are open to participants now.
This study's planned enrollment of 48 is close to the median of 44 across 169 interventional studies indexed under Post-Traumatic Headache.
Browse Post-Traumatic Headache studies →Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will receive the Graston technique with conventional treatment
Other: Graston technique
Patients will receive Myofascial release therapy with conventional treatment.
Other: Myofascial Release Therapy
* Applied to: Sternocleidomastoid, Upper trapezius, Levator scapulae, Suboccipitals and cervical paraspinals. * Duration: 5-7 minutes per session, depending on patient tolerance and therapist assessment. * Frequency: 2-3 sessions per week, for 4 weeks
* Manual release applied to same regions as above using sustained pressure and fascial stretch. * Duration: 7-10 minutes per session. * Frequency: 2-3 sessions per week, for 4 weeks.
Neck Disability Index (NDI)
Time frame: upto 4 weeks
Numeric Pain Rating Scale (NPRS)
Patient level of pain will be assessed using this scale. This scale ranges from 0 to 10. 0 indicates "no pain" and 10 indicates "worst pain".
Time frame: upto 4 weeks
Universal Goniometer (UG)
The range of motion will be measured using universal goniometer that has an inter-rater reliability (ICC2, 2 = 0.79 to 0.92) for cervical region
Time frame: upto 4 weeks
Global Rating of Change (GROC) scale
Global Rating of Change (GROC) scale
Time frame: upto 4 weeks
No study locations are listed for this record.
Plan to share: No
Start is estimated for Jul 2026; primary completion for Dec 2026, 5 months later.
Of 89 non-industry interventional studies with no phase under Post-Traumatic Headache, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 5 months is below that.
Counting every sponsor, half of 90 studies reached it within 12 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →